Beurs gesloten -
Andere beurzen
|
Nabeurs 20:40:00 | |||
146 EUR | -0,51% | 146,1 | +0,05% |
10:09 | MERCK KGAA : Barclays nog altijd een koopadvies | ZD |
18/04 | Studie: Amerikaanse bedrijven geven meer uit aan onderzoek dan Europese en Aziatische bedrijven | DP |
Vakgebied
- oplossingen en producten voor wetenschappelijk en biotechnologisch onderzoek (44,2%);
- farmaceutische producten (38,4%): geneesmiddelen op recept voor de behandeling van diabetes, kanker, multiple sclerose, onvruchtbaarheid, hart- en vaatziekten, aandoeningen van het centrale zenuwstelsel, ontstekingsziekten, enz;
- hoogwaardige materialen voor de elektronica-industrie (17,4%): halfgeleidermaterialen, vloeibare kristallen, pigmenten en additieven, organische materialen op koolstofbasis, enz.
De netto-omzet is geografisch als volgt verdeeld: Duitsland (4,8%), Europa (24%), China (12,9%), Azië/Pacific (20,1%), Verenigde Staten (26,8%), Noord-Amerika (1,6%), Latijns-Amerika (6,3%), Midden-Oosten en Afrika (3,5%).
Aantal werknemers: 62 908
Verkoop per activiteit
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Life Science
44,2
%
| 10 380 | 46,7 % | 9 281 | 44,2 % | -10,59% |
Healthcare
38,4
%
| 7 839 | 35,3 % | 8 053 | 38,4 % | +2,73% |
Electronics
17,4
%
| 4 013 | 18,1 % | 3 659 | 17,4 % | -8,82% |
Verkoop per regio
EUR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
28,2
%
| 6 302 | 28,3 % | 5 911 | 28,2 % | -6,20% |
Europe
21,0
%
| 4 524 | 20,3 % | 4 402 | 21,0 % | -2,70% |
Asia Pacific
19,9
%
| 4 479 | 20,1 % | 4 181 | 19,9 % | -6,65% |
China
11,8
%
| 2 818 | 12,7 % | 2 477 | 11,8 % | -12,10% |
Germany
6,8
%
| 1 532 | 6,9 % | 1 420 | 6,8 % | -7,31% |
Latin America
6,0
%
| 1 175 | 5,3 % | 1 267 | 6,0 % | +7,83% |
Middle East and Africa
2,5
%
| 516 | 2,3 % | 535 | 2,5 % | +3,68% |
Switzerland
2,4
%
| 592 | 2,7 % | 512 | 2,4 % | -13,51% |
North America
1,4
%
| 294 | 1,3 % | 287 | 1,4 % | -2,38% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 62 | 13-07-20 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 01-08-14 |
Director of Finance/CFO | 53 | 26-04-19 | |
Laura Matz
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-19 |
Danny Bar-Zohar
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-20 |
Constantin Fest
IRC | Investor Relations Contact | - | - |
Jeff White
PRN | Corporate Officer/Principal | - | - |
Andrew Paterson
SAM | Sales & Marketing | - | - |
Corporate Officer/Principal | - | 01-09-21 | |
Hong Chow
PRN | Corporate Officer/Principal | 53 | 01-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | - |
Jürgen Glaser
BRD | Director/Board Member | 61 | 01-05-12 |
Gabriele Eismann
BRD | Director/Board Member | 62 | 01-01-91 |
Dietmar Oeter
BRD | Director/Board Member | 57 | 01-01-95 |
Alexander Putz
BRD | Director/Board Member | 47 | 01-01-85 |
Director of Finance/CFO | 53 | 26-04-19 | |
Barbara Lambert
BRD | Director/Board Member | 62 | 11-08-23 |
Sascha Held
BRD | Director/Board Member | - | 26-04-19 |
Anne Lange
BRD | Director/Board Member | - | 26-04-19 |
Daniel Thelen
BRD | Director/Board Member | - | 26-04-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 305 535 626 | 0 | 0 | 29,71 % |
Aandeel B | 1 | 129 242 252 | 129 159 619 ( 99,94 %) | 0 |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
2 787 509 | 4.65% | 140 016 577 $ | |
PT MERCK TBK 86.65% | 388 194 920 | 86.65% | 97 693 134 $ |
VERA THERAPEUTICS, INC. 3.48% | 1 913 501 | 3.48% | 82 510 163 $ |
PRECIGEN, INC. 8.29% | 20 647 152 | 8.29% | 29 938 370 $ |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. |
Miscellaneous Commercial Services
|
Pharmaceuticals: Major
| |
Ares Trading SA
| |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. |
Medical Specialties
|
AZ Electronic Materials (Japan) KK
AZ Electronic Materials (Japan) KK Chemicals: SpecialtyProcess Industries AZ Electronic Materials (Japan) KK manufactures plastic materials and inorganic chemicals. The company is located in Tokyo, Japan |
Chemicals: Specialty
|
Merck Santé SASU
Merck Santé SASU Pharmaceuticals: MajorHealth Technology Merck Santé SAS manufactures pharmaceutical products. The company is headquartered in Lyon, France. |
Pharmaceuticals: Major
|
Merck Financial Services GmbH
Merck Financial Services GmbH Finance/Rental/LeasingFinance Part of Merck KGaA, Merck Financial Services GmbH provides financing operations and activities. The private company is based in Darmstadt, Germany. The CEOs are Jörg Bermüller, Rando Bruns. The German company was founded in 2007. |
Finance/Rental/Leasing
|
Millipore SAS
Millipore SAS Electronic Equipment/InstrumentsElectronic Technology Founded in 1972, Millipore SAS is a subsidiary of Merck KGaA that provides industrial instruments for measurement. The private company is based in Molsheim, France. |
Electronic Equipment/Instruments
|
Merck Life Science A/S
Merck Life Science A/S Electronic Equipment/InstrumentsElectronic Technology Part of Merck KGaA, Merck Life Science A/S is a Danish company that provides industrial instruments for measurement. The private company is located in Denmark. |
Electronic Equipment/Instruments
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,32% | 68,04 mld. | |
+10,08% | 9,12 mld. | |
-17,63% | 4,8 mld. | |
+0,73% | 3,8 mld. | |
+16,55% | 3,72 mld. | |
+27,76% | 2,58 mld. | |
-26,11% | 2,36 mld. | |
-30,09% | 2,11 mld. | |
+7,15% | 1,86 mld. | |
-0,50% | 1,64 mld. |